182 related articles for article (PubMed ID: 32776380)
21. Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).
Patek TM; Teng C; Kennedy KE; Alvarez CA; Frei CR
Drug Saf; 2020 Jan; 43(1):17-22. PubMed ID: 31691256
[TBL] [Abstract][Full Text] [Related]
22. [Risk factors for development of hematotoxicity in elderly patients treated with Linezolid].
Bo SY; Su AM; Yang F; Yang L
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jun; 45(6):533-538. PubMed ID: 35658376
[No Abstract] [Full Text] [Related]
23. Severe linezolid-induced lactic acidosis in a child with acute lymphoblastic leukemia: A case report.
Smolka V; Rohanova M; Ludikova B; Novak Z; Zapalka M; Pospisilova D; Volejnikova J
J Infect Chemother; 2020 Dec; 26(12):1316-1318. PubMed ID: 32859497
[TBL] [Abstract][Full Text] [Related]
24. Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilance-pharmacokinetic/pharmacodynamic analysis.
Gatti M; Raschi E; De Ponti F
Eur J Clin Pharmacol; 2021 Feb; 77(2):233-239. PubMed ID: 32901348
[TBL] [Abstract][Full Text] [Related]
25. Torsades de pointes and QT prolongation Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System.
Teng C; Walter EA; Gaspar DKS; Obodozie-Ofoegbu OO; Frei CR
Int J Med Sci; 2019; 16(7):1018-1022. PubMed ID: 31341415
[No Abstract] [Full Text] [Related]
26. Number of concomitant drugs with thrombocytopenic adverse effects and the extent inflammatory response resolution are risk factors for thrombocytopenia in patients treated with linezolid for more than 14 days.
Sato Y; Iguchi M; Kato Y; Morioka H; Hirabayashi A; Tetsuka N; Tomita Y; Kato D; Yamada K; Kimura H; Yagi T
Nagoya J Med Sci; 2020 Aug; 82(3):407-414. PubMed ID: 33132425
[TBL] [Abstract][Full Text] [Related]
27. Linezolid Consumption Facilitates the Development of Linezolid Resistance in
Bai B; Hu K; Zeng J; Yao W; Li D; Pu Z; Chen Z; Cheng H; Zheng J; Pan W; Lin Z; Xie L; Deng Q; Yu Z
Microb Drug Resist; 2019; 25(6):791-798. PubMed ID: 30762463
[TBL] [Abstract][Full Text] [Related]
28. Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.
Britt NS; Potter EM; Patel N; Steed ME
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264856
[TBL] [Abstract][Full Text] [Related]
29. Significance of data mining in routine signal detection: Analysis based on the safety signals identified by the FDA.
Fukazawa C; Hinomura Y; Kaneko M; Narukawa M
Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1402-1408. PubMed ID: 30324671
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic and pharmacodynamic simulation for the quantitative risk assessment of linezolid-associated thrombocytopenia.
Onita T; Ishihara N; Ikebuchi A; Yano T; Nishimura N; Tamaki H; Ikawa K; Morikawa N; Naora K
J Clin Pharm Ther; 2022 Dec; 47(12):2041-2048. PubMed ID: 35893441
[TBL] [Abstract][Full Text] [Related]
31. Adverse event profiles of ifosfamide-induced encephalopathy analyzed using the Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases.
Shimada K; Hasegawa S; Nakao S; Mukai R; Matsumoto K; Tanaka M; Uranishi H; Masuta M; Nishida S; Shimizu S; Hayashi Y; Suzuki A; Nakamura M
Cancer Chemother Pharmacol; 2019 Nov; 84(5):1097-1105. PubMed ID: 31502115
[TBL] [Abstract][Full Text] [Related]
32. Early lactic acidosis associated with linezolid therapy in paediatric patients.
Ozkaya-Parlakay A; Kara A; Celik M; Ozsurekci Y; Karadag Oncel E; Ceyhan M; Cengiz AB
Int J Antimicrob Agents; 2014 Oct; 44(4):334-6. PubMed ID: 25182713
[TBL] [Abstract][Full Text] [Related]
33. Colitis following the use of immune checkpoint inhibitors: A real-world analysis of spontaneous reports submitted to the FDA adverse event reporting system.
Hu Y; Gong J; Zhang L; Li X; Li X; Zhao B; Hai X
Int Immunopharmacol; 2020 Jul; 84():106601. PubMed ID: 32422528
[TBL] [Abstract][Full Text] [Related]
34. Hypoglycemia Associated with Antibiotics Alone and in Combination with Sulfonylureas and Meglitinides: An Epidemiologic Surveillance Study of the FDA Adverse Event Reporting System (FAERS).
Kennedy KE; Teng C; Patek TM; Frei CR
Drug Saf; 2020 Apr; 43(4):363-369. PubMed ID: 31863282
[TBL] [Abstract][Full Text] [Related]
35. Linezolid-Induced Thrombocytopenia Is Caused by Suppression of Platelet Production via Phosphorylation of Myosin Light Chain 2.
Tajima M; Kato Y; Matsumoto J; Hirosawa I; Suzuki M; Takashio Y; Yamamoto M; Nishi Y; Yamada H
Biol Pharm Bull; 2016; 39(11):1846-1851. PubMed ID: 27803456
[TBL] [Abstract][Full Text] [Related]
36. Linezolid-induced lactic acidosis.
Ramesh V; Gattu S; Maqsood M; Rao V
BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38331448
[TBL] [Abstract][Full Text] [Related]
37. Association of clinical factors with thrombocytopenia in patients receiving linezolid treatment: a retrospective study.
Thi Phuong Thao L; Duc Trung N; Thi My L; Minh Hong L; Viet Hoan B; Quang Hung V; Dang Hai P
J Infect Dev Ctries; 2024 Feb; 18(2):285-290. PubMed ID: 38484357
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System.
Poluzzi E; Raschi E; Motola D; Moretti U; De Ponti F
Drug Saf; 2010 Apr; 33(4):303-14. PubMed ID: 20297862
[TBL] [Abstract][Full Text] [Related]
39. Cardiotoxicity in targeted therapy for breast cancer: A study of the FDA adverse event reporting system (FAERS).
Wittayanukorn S; Qian J; Johnson BS; Hansen RA
J Oncol Pharm Pract; 2017 Mar; 23(2):93-102. PubMed ID: 26661047
[TBL] [Abstract][Full Text] [Related]
40. Rhabdomyolysis Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).
Teng C; Baus C; Wilson JP; Frei CR
Int J Med Sci; 2019; 16(11):1504-1509. PubMed ID: 31673242
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
